Advertisement

Advertisement

European Hematology Association 2024 Congress

By Chase Doyle / August 25, 2024 / European Hematology Association 2024 Congress

Acalabrutinib Plus Chemoimmunotherapy Improves Progression-Free Survival in Older Patients With Mantle Cell Lymphoma

Combining Bruton’s tyrosine kinase (BTK) inhibition with chemoimmunotherapy induction significantly extended progression-free survival for older patients with mantle cell lymphoma, and there was also ...

By Chase Doyle / August 25, 2024 / European Hematology Association 2024 Congress

Glofitamab Combination Therapy Shows Survival Benefit in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

A novel treatment regimen with the bispecific antibody glofitamab has demonstrated improvements in survival outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), acc...

Advertisement

Advertisement

Sep

10

Today In Oncology

IASLC: AI Method Transforms Gene Mutation Prediction in Lung Cancer

Treating TKI-Resistant, EGFR-Mutant, Metastatic Nonsquamous NSCLC

IASLC: Ifinatamab Deruxtecan in Extensive-Stage Small Cell Lung Cancer

Youth E Cigarette Use May Have Declined to Lowest Level in a Decade

High Proportion of US Men Older Than 45 Years May Have Misconceptions About Prostate Cancer Screening as Rates of Late Stage Diagnoses Continue to Rise

Advertisement

© 2024 HSP News Service, L.L.C.